Sun Pharma Advanced Research Share Price Falling Today: Stock Drops 5.64% to Rs 236.33 on 17 July 2026
- July 17, 2026
- Posted by: Neeraj Pandey
- Category: News
Sun Pharma Advanced Research share price falling today, down 5.64% to Rs 236.33. Day range Rs 228.15 to Rs 250.49. Volume 22.12 lakh.
The Sun Pharma Advanced Research share price is falling today, down 5.64% to Rs 236.33 on the NSE in trade on 17 July 2026, as Sun Pharma Advanced Research features among the top losers in the broader market. The stock opened at Rs 250.49 against the previous close of Rs 250.45 and has moved between a low of Rs 228.15 and a high of Rs 250.49 during the session.
Trading volumes have been elevated, with around 22.12 lakh shares changing hands, reflecting strong participation behind today’s move. Sun Pharma Advanced Research Company has a long history of sharp single day price swings in both directions, reflecting its nature as a clinical stage, pre-revenue biopharmaceutical company.
Click Here – Get Free Investment Predictions
Sun Pharma Advanced Research Share Price Falling Today: Trading Snapshot
The table below summarises the Sun Pharma Advanced Research share price action as of the latest trade on 17 July 2026.
| Parameter | Value |
|---|---|
| CMP | Rs 236.33 |
| Change | -5.64% |
| Day Open | Rs 250.49 |
| Day High | Rs 250.49 |
| Day Low | Rs 228.15 |
| Previous Close | Rs 250.45 |
| Volume | 22.12 lakh shares |
Prices and volumes are from trade on 17 July 2026 and will keep changing through the session. The Sun Pharma Advanced Research share price falling today against this kind of elevated volume base typically signals more than routine day to day trading interest.
Consult a SEBI-Registered Investment Advisor at Univest
Why the Sun Pharma Advanced Research Share Price Is Falling Today
Sun Pharma Advanced Research Company, a clinical stage biopharmaceutical company spun off from Sun Pharmaceutical Industries, is down 5.64 percent today. The stock has a well documented history of large single day moves in both directions, since as an R&D focused company with limited near term revenue, its valuation is heavily driven by sentiment around drug pipeline progress, trial outcomes, and licensing deal prospects rather than conventional earnings metrics.
No specific negative trial or regulatory announcement was identified at the time of writing, which is consistent with the stock’s pattern of high volatility even in the absence of confirmed news, given how speculative sentiment tends to dominate trading in clinical stage pharmaceutical companies with binary outcome risk on their pipeline assets.
About Sun Pharma Advanced Research
Sun Pharma Advanced Research Company is a clinical stage biopharmaceutical company focused on novel drug delivery platforms and new chemical entities, working on out-licensing deals for its proprietary technologies with global pharmaceutical partners.
Sun Pharma Advanced Research Share Price Falling Today: What Should Investors Watch
Investors should watch for any official company announcements on trial results, regulatory milestones, or licensing deals, and should recognise that the stock’s high volatility reflects its early stage, binary outcome business model rather than predictable operating trends.
Investors should avoid chasing the Sun Pharma Advanced Research share price purely because it is falling today, and instead evaluate whether the underlying business rationale supports the move before making any investment decision.
Download the Univest iOS App or Univest Android App to track the Sun Pharma Advanced Research share price live and get daily stock research.
Conclusion
The Sun Pharma Advanced Research share price is falling today, down 5.64% to Rs 236.33 on 17 July 2026, with volumes well above typical levels. Today’s sharp decline is consistent with the stock’s well established pattern of high volatility as a clinical stage, pre-revenue biopharmaceutical company. Investors should track further developments and consult a SEBI-registered advisor before making investment decisions based on the Sun Pharma Advanced Research share price falling today.
Momentum traders watching the Sun Pharma Advanced Research share price falling today often use volume confirmation, like today’s elevated turnover, as a signal that the move has genuine participation behind it rather than being a thin, low-volume spike.
Analysts typically wait for a day or two of follow-through before treating a single session’s rise in the Sun Pharma Advanced Research share price as the start of a sustained trend rather than a one-off event.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
Why is the Sun Pharma Advanced Research share price falling today?
Ans. The Sun Pharma Advanced Research share price is falling today, down 5.64% to Rs 236.33 on 17 July 2026. Sun Pharma Advanced Research Company is down 5.64 percent today, consistent with its history of large single day price swings as a clinical stage biopharmaceutical company where sentiment around pipeline progress drives valuation.
What is the Sun Pharma Advanced Research share price today?
Ans. The Sun Pharma Advanced Research share price is trading at Rs 236.33 on the NSE on 17 July 2026, down 5.64% from the previous close of Rs 250.45, with the stock moving between Rs 228.15 and Rs 250.49 during the session.
How much trading volume has Sun Pharma Advanced Research seen today?
Ans. Sun Pharma Advanced Research has traded with volumes of around 22.12 lakh shares so far today, reflecting elevated participation compared to typical sessions.
What does Sun Pharma Advanced Research do?
Ans. Sun Pharma Advanced Research Company is a clinical stage biopharmaceutical company, spun off from Sun Pharmaceutical Industries, focused on novel drug delivery platforms and new chemical entities.
Is the Sun Pharma Advanced Research share price falling today a buying signal?
Ans. A single day’s rise is not a reliable buying signal on its own. Evaluate the underlying business rationale, valuations, and your own risk appetite before making any investment decision, and consult a SEBI-registered advisor.
What should investors watch for the Sun Pharma Advanced Research share price?
Ans. Watch for official announcements on trial results, regulatory milestones, or licensing deals, and recognise the stock’s inherent high volatility as an early stage R&D company.
Where can I track the Sun Pharma Advanced Research share price live?
Ans. You can track the Sun Pharma Advanced Research share price live on NSE and BSE, or on the Univest app, which also provides daily research and market updates on Indian stocks.
